Mauna Kea Technologies announces that its stake has begun to be covered by Portzamparc – BNP Paribas Group
PARIS and BOSTON, January 30, 2023–(BUSINESS WIRE)–Regulatory News:
Mauna Kea Technologies (Euronext: MKEA) (Paris: MKEA) (OTCQX: MKEAY), inventor of Cellvizio®, a multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the launch of its name coverage by Portzamparc – BNP Paribas Group.
Portzamparc – BNP Paribas Group has started monitoring the stock, recommending a Buy value in a research called “Eruption of a new model”.
***
Further financial information: Annual results for 2022, after market close on April 6, 2023
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company that manufactures and markets Cellvizio®, a real-time in vivo mobile imaging platform. This technology provides unique in vivo cellular visualization that allows physicians to monitor disease progression over time, assess ongoing responses, classify areas of uncertainty, and guide surgical interventions. The Cellvizio platform is used in many countries around the world and in several medical specialties, and is changing the way doctors diagnose and treat patients. For more information, visit www.maunakeatech.com.
Warning
This press release contains forward-looking statements regarding Mauna Kea Technologies and its business. All statements other than historical facts contained in this press release, including those relating to Mauna Kea Technologies’ financial condition, business, strategies, plans and objectives for future operations, are forward-looking statements. Mauna Kea Technologies believes that these forward-looking statements are based on reasonable assumptions. However, there can be no assurance that the projections expressed in these forward-looking statements will be achieved, which are subject to numerous risks and uncertainties, including those described in Chapter 3 of the Mauna Kea Technologies 2021 Universal Registration Document filed with the Autorité. des marchés financiers (AMF) dated October 18, 2022 under number D-22-0773, on the Company’s website (www.maunakeatech.fr), as well as risks related to changes in economic conditions, financial markets and markets in which Mauna Kea Technologies operates . Forward-looking statements contained in this press release are also subject to risks unknown to Mauna Kea Technologies or of which Mauna Kea Technologies did not consider the material as of this date. The realization of all or part of these risks could cause Mauna Kea Technologies’ actual results, financial conditions, performance or achievements to differ materially from those expressed in these forward-looking statements. This press release and the information it contains are not an offer to sell or subscribe, nor a solicitation of an order to buy or subscribe for shares of Mauna Kea Technologies in any jurisdiction where such offer, solicitation or sale would be illegal. registration or qualification under the securities laws of such jurisdiction. Distribution of this press release may be restricted by local law in some jurisdictions. Persons in possession of this document are responsible for compliance with all local regulations applicable to this document.
See the source version at businesswire.com: https://www.businesswire.com/news/home/20230130005436/en/
contacts
Investor Relations
NewCap – Financial communication
Aurélie Manavarere / Thomas Grojean
+33 (0)1 44 71 94 94
maunakea@newcap.eu
